The epidemiologic trend of respiratory syncytial virus has returned strongly to its origin after the pandemic: Five-year data from a single center

Basit Öğe Kaydı
dc.contributor.authorCaglar, Hanife Tugce
dc.contributor.authorPekcan, Sevgi
dc.contributor.authorYilmaz, Asli Imran
dc.contributor.authorUnal, Gokcen
dc.contributor.authorErcan, Fatih
dc.contributor.authorSavas, Suat
dc.contributor.authorAkcan, Ozge Metin
dc.date.accessioned2024-02-23T13:03:31Z
dc.date.available2024-02-23T13:03:31Z
dc.date.issued2023
dc.departmentNEÜen_US
dc.description.abstractObjective: Only a few studies have investigated the frequency and severity of respiratory syncytial virus (RSV) infections after the end of the pandemic regulations. This study aims to investigate the frequency and severity of RSV infections before, during, and after the pandemic in Turkey.Materials and Methods: Patients under 18 years of age and those who tested positive for RSV between April 2018 and March 2023 were retrospectively reviewed. All patients were divided into three groups (pre-COVID-19, COVID-19, and post-COVID-19) according to admission date. Among inpatients, data were compared between the three groups to determine the impact of the pandemic on RSV epidemiology and clinical outcomes.Results: A total of 9567 patients were tested for RSV, of which 1073 (11.2%) were positive and included in the study. Hospitalization occurred in 447 (41.7%) patients. Inpatients were younger than outpatients (p < .000). Among the three inpatient pandemic groups, clinical outcomes were statistically significantly worse in the post-COVID-19 group than in the other two groups. SpO(2) was lower (p < .000), inhaled salbutamol requirement was higher (p < .000), length of stay was longer (p = .031), and ICU admission was higher (p = .023).Conclusion: Although the RSV trend changed within 2 years after the COVID-19 outbreak, it returned to its usual seasonality last year. After the repeal of all COVID-19 measures and the normal life began, the number of RSV-positive patients and RSV-related hospitalizations increased, and the clinical outcomes of RSV worsened. This may be a result of decreased herd immunity due to a change in society's attitude toward epidemic diseases.en_US
dc.description.sponsorshipNone.en_US
dc.description.sponsorshipNone.en_US
dc.identifier.doi10.1002/ppul.26696
dc.identifier.endpage3587en_US
dc.identifier.issn8755-6863
dc.identifier.issn1099-0496
dc.identifier.issue12en_US
dc.identifier.pmid37737535en_US
dc.identifier.scopus2-s2.0-85171763996en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage3582en_US
dc.identifier.urihttps://doi.org/10.1002/ppul.26696
dc.identifier.urihttps://hdl.handle.net/20.500.12452/10658
dc.identifier.volume58en_US
dc.identifier.wosWOS:001069726200001en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofPediatric Pulmonologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCovid-19en_US
dc.subjectPandemic Regulationsen_US
dc.subjectRespiratory Syncytial Virusen_US
dc.subjectRsven_US
dc.subjectSeasonalityen_US
dc.titleThe epidemiologic trend of respiratory syncytial virus has returned strongly to its origin after the pandemic: Five-year data from a single centeren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu